Coeptis Therapeutics Holdings Inc. Common Stock logo

COEP

Financials

Coeptis Therapeutics Holdings Inc. Common Stock

$16.40+0.17 (+1.05%)PRE

Live · XNAS · May 9, Close

AI Insight

What's Moving COEP Today?

No stock-specific AI insight has been generated for COEP yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$102M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume
Avg Volume (10D)
Shares Outstanding6.2M

Price Data

Open$0.00
Previous Close$16.40
Day High$0.00
Day Low$0.00
52 Week High
52 Week Low

About Coeptis Therapeutics Holdings Inc. Common Stock

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

6 employees
Listed October 31, 2022
FinancialsFINANCE SERVICES

Company Details

Security Type
ExchangeNASDAQ
Currency
Round Lot
SICFINANCE SERVICES
CIK
Composite FIGI
Share Class FIGI